Overview
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring copper-binding tripeptide first identified in human plasma by Dr. Loren Pickart in 1973. Present in blood, saliva, and urine, GHK-Cu levels naturally decline with age—from approximately 200 ng/mL in young adults to 80 ng/mL by age 60—a decline that correlates with reduced regenerative capacity.
The peptide's biological activity stems from its ability to bind copper(II) ions with high affinity and deliver them to tissues where they serve as cofactors for numerous enzymatic processes including collagen synthesis, elastin production, and glycosaminoglycan formation. This copper-delivery mechanism triggers a cascade of regenerative signals that promote wound healing, skin remodeling, and tissue repair.
GHK-Cu has been incorporated into numerous cosmeceutical products and has accumulated a substantial body of research spanning dermatology, wound care, and anti-aging medicine. Unlike many peptides in the regenerative space, GHK-Cu has human clinical data supporting its topical efficacy for skin rejuvenation, making it one of the better-validated peptides for cosmetic and dermatological applications.
This guide examines GHK-Cu's molecular mechanisms, clinical evidence base, formulation considerations, and its emerging applications beyond skin care including neuroprotection, COPD, and cancer research.
Quick facts
- Mechanism
- Copper-delivery tripeptide activating regenerative gene expression
- Primary use
- Skin Rejuvenation & Wound Healing
- Evidence
- moderate
- FDA
- Not approved
- Route
- Topical application, subcutaneous injection, or microneedling
- Typical results
- Visible skin improvement in 4–8 weeks; wound healing acceleration in animal models
Chemical information
GHK-Cu (C₁₄H₂₂CuN₆O₄) is a regeneration compound with a molecular weight of 340.38 g/mol. Its structural characteristics underpin its biological activity in tissue repair and regeneration.
How GHK-Cu works
GHK-Cu functions primarily as a biological signaling molecule that modulates gene expression on a genome-wide scale. Research has identified over 4,000 human genes whose expression is significantly altered by GHK-Cu, with the overall pattern shifting gene activity toward a healthier, more youthful profile. The copper(II) ion bound to the GHK tripeptide serves as both a signaling molecule and a catalytic cofactor for enzymes critical to tissue repair.
In skin, GHK-Cu stimulates collagen types I, III, and V synthesis while simultaneously activating matrix metalloproteinases (MMPs) that break down damaged collagen and scar tissue. This balanced remodeling process—building new collagen while removing damaged tissue—is unique to GHK-Cu and distinguishes it from agents that simply stimulate collagen production. The peptide also promotes elastin synthesis and decorin production, improving skin elasticity and structural integrity.
GHK-Cu is a potent activator of the TGF-β superfamily signaling cascade, which drives fibroblast differentiation and extracellular matrix production. It simultaneously recruits immune cells to wound sites while modulating the inflammatory response to prevent excessive scarring. Studies show GHK-Cu can reduce the expression of pro-fibrotic genes associated with hypertrophic scarring.
Beyond dermatological applications, GHK-Cu has shown neuroprotective properties by upregulating antioxidant genes (SOD, glutathione peroxidase) and neurotrophic factors (NGF, BDNF). Research has also identified anti-cancer properties, with GHK-Cu resetting the gene expression of metastasis-related genes toward a less aggressive phenotype.
- Genome-wide gene modulation: Alters expression of 4,000+ genes toward a healthier, regenerative profile
- Copper cofactor delivery: Provides Cu²⁺ ions essential for lysyl oxidase, superoxide dismutase, and other repair enzymes
- Collagen remodeling: Stimulates new collagen synthesis while activating MMPs to remove damaged tissue
- Antioxidant activation: Upregulates SOD, glutathione peroxidase, and other cellular defense systems
- Anti-inflammatory signaling: Reduces TNF-α and IL-6 while modulating TGF-β for balanced wound healing
- Stem cell attraction: Promotes migration of mesenchymal stem cells to injury sites
Pharmacokinetics
| Parameter | Value | Significance |
|---|---|---|
| Topical penetration | Stratum corneum permeable | Effective in topical formulations at 1–3% |
| Plasma half-life | ~1 hour | Short half-life supports frequent topical application |
| Natural plasma levels | 200 ng/mL (age 20) | Declines to 80 ng/mL by age 60 |
| Copper binding affinity | Kd = 10⁻¹⁶ M | Extremely high affinity for Cu²⁺ ions |
| Molecular weight | 340.38 g/mol | Small enough for dermal penetration |
Dosing & administration
GHK-Cu dosing varies by indication and individual factors. No FDA-approved dosing exists for this compound; protocols in the literature derive from limited clinical or preclinical data and practitioner experience.
Any use should be conducted under qualified medical supervision with appropriate monitoring of safety markers.
Important: These dosing ranges are not FDA-approved. Any use should be under qualified medical supervision.
Side effects & safety
Safety data for GHK-Cu is primarily derived from preclinical studies and limited human data. Long-term effects in humans remain incompletely characterized.
Common
- • Injection site reactions (redness, swelling)
- • Mild headache
- • Temporary fatigue
- • Nausea (dose-dependent)
- • Flushing
Serious / potential risks
- • Allergic reactions (rare)
- • Hormonal disruption with prolonged unsupervised use
- • Potential drug interactions
- • Unknown long-term effects in humans
Drug interactions
| Medication | Interaction | Recommendation |
|---|---|---|
| Retinoids (tretinoin, adapalene) | Both stimulate collagen; potential for skin irritation when combined topically | Alternate application times; monitor for excessive dryness |
| Vitamin C serums | Copper may oxidize ascorbic acid, reducing efficacy of both | Apply at different times of day |
| AHA/BHA exfoliants | Acids may alter copper peptide stability and penetration | Use on alternate days or separate by several hours |
| Zinc supplements (high dose) | Zinc competes with copper absorption systemically | If using injectable GHK-Cu, monitor copper/zinc balance |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| Research suppliers | Varies widely | Quality and purity vary significantly between sources |
| Compounding pharmacies | Prescription required | Higher quality assurance and purity testing |
The bottom line
GHK-Cu is a regeneration compound with research interest in wound healing, skin rejuvenation, collagen, hair growth. While preclinical evidence is encouraging, it remains investigational and is not FDA-approved. Any use should be under qualified medical supervision.
Best for
- • Researchers studying tissue repair and regeneration
- • Individuals interested in wound healing under medical guidance
Not for
- • Self-administration without medical supervision
- • Pregnant or breastfeeding individuals
- • Individuals with contraindicated conditions
Related compounds
AHK-Cu
Related copper tripeptide with complementary wound healing properties
BPC-157
Gastric pentadecapeptide with systemic tissue repair capabilities
Epitalon
Anti-aging tetrapeptide targeting telomerase for cellular longevity
SNAP-8
Expression-line peptide used in anti-aging skincare protocols
Frequently asked questions
References
- [1] Pickart L, Vasquez-Soltero JM, Margolina A.. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int (2015). doi: 10.1155/2015/648108 PMID: 25866791
- [2] Pickart L, Vasquez-Soltero JM, Margolina A.. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev (2012). doi: 10.1155/2012/324832 PMID: 22666519
- [3] Arul V, Kartha R, Jayakumar R.. A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sci (2007). doi: 10.1016/j.lfs.2006.09.018 PMID: 17049946
- [4] Pickart L.. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed (2008). doi: 10.1163/156856208784909435 PMID: 18925866
- [5] Campbell JD, McDonough JE, Zeskind JE, et al.. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med (2012). doi: 10.1186/gm368 PMID: 23146165